MedTrace Logo

Physical Exercise to Reduce Anxiety in Underserved Children With ASD

NCT02902952 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2023-04-04

No results posted yet for this study

Summary

Anxiety is one of the most frequent comorbidities in children with ASD leading to poor clinical outcomes. Physical exercise has been shown to be a promising and easy to implement intervention for reducing anxiety. However, little is known about the feasibility and efficacy of physical exercise to reduce anxiety in children with ASD from underserved, low-income families. Children with ASD, ages 6 - 12 years old from low-income and Latino families will be recruited for the study and assigned to an exercise intervention group and a sedentary control group. The physical exercise program is an eight-week program, administered three times per week in small groups. Compliance, parent-rated anxiety, and salivary cortisol will be measured before and after completion of the exercise and control group interventions.

Conditions

  • Physical Exercise Condition
  • Control Condition

Interventions

BEHAVIORAL

Physical Exercise

An eight week physical exercise intervention

BEHAVIORAL

Control Intervention

An eight week sedentary control intervention

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • University of Missouri-Columbia

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Jean Gehricke, Ph.D. · University of California, Irvine

  • Lea Ann Lowery, OTD/OTR-L · University of Missouri-Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02902952 on ClinicalTrials.gov